← Scroll for more →
Krystal Biotech, Inc. (KRYS)
Biological Products, (No Diagnostic Substances)
Latest Price
$332.56
TTM P/E
41.73
Normalized P/E
222.17
Div Yield
--
Book Value
46.10
P/B Ratio
7.21
Valuation metrics
adjust assumptions →EPS: $6.84
Book value / share: $41.78
Formula: √(22.5 × EPS × BVPS)
Graham Number
$80.18
76% downside
Base FCF: $154M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$409.73
+23% upside
EPS: $6.84
Target P/E: 42×
Formula: EPS × P/E
P/E Fair Value
$287.28
14% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 4.42M | $1.64B | 14.93% | +44.2K | 2026-06-30 |
| BlackRock, Inc. | 4.18M | $1.55B | 14.13% | +241.0K | 2026-06-30 |
| Avoro Capital Advisors LLC | 2.89M | $1.07B | 9.76% | -- | 2026-06-30 |
| Vanguard Portfolio Management LLC | 1.57M | $585.0M | 5.32% | +118.2K | 2026-06-30 |
| State Street Corp | 1.35M | $502.0M | 4.57% | +36.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.24M | $461.0M | 4.19% | +75.2K | 2026-06-30 |
| Soleus Capital Management, L.P. | 939.3K | $349.0M | 3.17% | -213.8K | 2026-06-30 |
| Capital World Investors | 777.8K | $289.0M | 2.63% | -46.9K | 2026-06-30 |
| Vestor Capital, LLC | 700.9K | $78.0M | 2.37% | +700.7K | 2026-06-30 |
| Geode Capital Management, LLC | 699.0K | $259.0M | 2.36% | +55.0K | 2026-06-30 |